See more : EURO Ressources S.A. (EUR.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Aladdin Healthcare Technologies SE (ALDNF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aladdin Healthcare Technologies SE, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Randolph Bancorp, Inc. (RNDB) Income Statement Analysis – Financial Results
- OK Science and Technology Co., Ltd. (001223.SZ) Income Statement Analysis – Financial Results
- Hua Medicine (Shanghai) Ltd. (2552.HK) Income Statement Analysis – Financial Results
- Beijing Jingxi Culture & Tourism Co.,Ltd (000802.SZ) Income Statement Analysis – Financial Results
- Guangdong New Grand Long Packing Co., Ltd. (002836.SZ) Income Statement Analysis – Financial Results
Aladdin Healthcare Technologies SE (ALDNF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.aladdinid.com
About Aladdin Healthcare Technologies SE
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 174.49K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 21.58K | 1.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -21.58K | -1.73K | 174.49K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 229.99K | 547.91K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 327.55K | 855.80K | 537.08K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 12.00K | 1.47K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 339.55K | 857.27K | 537.08K | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 11.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 1.04M | 1.79M | 1.91M | 25.86K | 95.69K | 9.00K |
| Cost & Expenses | 0.00 | 0.00 | 1.04M | 1.79M | 1.91M | 25.86K | 95.69K | 9.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 95.26K | 24.64K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 116.44K | 72.33K | 61.29K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 21.58K | 1.53M | 1.47K | 52.52K | 22.82K | 0.00 |
| EBITDA | 0.00 | 0.00 | -1.31M | -180.72K | -1.71M | -25.86K | -95.69K | -9.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -979.05% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | -1.33M | -1.71M | -3.84M | -25.86K | -95.69K | -9.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2,198.57% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -395.81K | -1.49M | -1.14M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -1.44M | -3.32M | -3.87M | -25.86K | -95.69K | -9.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2,219.58% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -207.37K | -329.26K | 2.13M | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | -1.23M | -2.99M | -3.87M | -25.86K | -95.69K | -9.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2,219.58% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.11 | -0.19 | -0.35 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.11 | -0.19 | -0.35 | 0.00 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 11.46M | 15.66M | 10.97M | 11.53M | 11.53M | 11.53M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 11.46M | 15.66M | 10.97M | 11.53M | 11.53M | 11.53M |
Source: https://incomestatements.info
Category: Stock Reports